<DATE> 9-MAR-1987 10:41:25.30</DATE>
<TOPICS></TOPICS>
<PLACES><D>usa</D></PLACES>
<PEOPLE></PEOPLE>
<ORGS></ORGS>
<EXCHANGES></EXCHANGES>
<COMPANIES></COMPANIES>
<UNKNOWN> 
&#5;&#5;&#5;F
&#22;&#22;&#1;f0339&#31;reute
r f BC-CIBA-GIEGY-IN-PACT-TO   03-09 0091</UNKNOWN>
<TEXT>&#2;
<TITLE>CIBA-GIEGY IN PACT TO MAKE GALLSTONE DISSOLVER</TITLE>
<DATELINE>    SUMMIT, N.J., March 9 - </DATELINE><BODY>&lt;Ciba-Giegy Corp>'s Ciba-Giegy 
Pharmaceuticals division said it had an agreement with
&lt;Gipharmex S.P.A.> (Giuliani Group), of Milan, Italy, to
develop and eventually market in the U.S. a new gallstone
dissolving drug.
    The company said the drug, ursodeoxycholic acid, is a
naturally occurring bile acid and has been approved for
marketing in most European countries and in Japan.
    The division said it holds a patent on the use of the drug
to dissolve gallstones.
 Reuter
&#3;</BODY></TEXT>